skip to navigation skip to content
search
  • About us
    • Networking events
      • SAPG celebrates 15 years
    • Minutes of meetings
    • Latest updates
      • SAPG reflections on 2024
      • Media release: Expert warns of the dangers of using old antibiotics
      • SAPG@15 Event
      • SAPG reflections on 2023
      • Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS)
      • SAPG reflections on 2022
  • Guidance & QI Tools
    • Antimicrobial-specific guidance
      • Aminoglycoside use in empirical prescribing guidelines
      • Chloramphenicol prescribing in adult patients - consensus guidance
      • Guidance on the intravenous use of colistimethate sodium (colistin) in adults
      • Gentamicin (5mg/kg)
      • Gentamicin - Hartford (7mg/kg)
      • Vancomycin
      • Statement on updated MHRA fluoroquinolone advice
    • Infection-specific guidance
      • Acne and rosacea
      • Clostridioides difficile (C.diff) infection (CDI)
      • Staphylococcus aureus bacteraemia (SAB)
      • Urinary tract infections (UTIs)
      • Neutropenic sepsis and febrile neutropenia
    • Good practice recommendations
      • Antimicrobial use in frail older people
      • Antibiotics towards the end of life
      • Antifungals
      • Care homes
      • Hospital antimicrobial stewardship
      • Surgical prophylaxis
    • Dental stewardship
    • Outpatient parenteral antimicrobial therapy (OPAT)
    • Paediatric stewardship
      • Resources for the management of children with respiratory tract infections
      • Antimicrobial management of Clostridioides difficile (C.diff) Infection (CDI) in children
    • Information for patients and non-clinical staff
    • Quality improvement tools
      • GP audit tool
      • Hospital Antibiotic Review Programme (HARP)
      • Penicillin Allergy De-labelling
      • Scottish Reduction in Antimicrobial Prescribing (ScRAP)
      • Setting up Vision defaults
    • Guidance from other organisations
    • Right Decision Service App - Antimicrobial guidance
  • Publications
    • 2020 to date
    • 2011-2019
    • Ghana partnership
    • Other reports
  • Education Resources
    • Antibiotic Awareness
      • World AMR Awareness Week (WAAW)
      • Keep Antibiotics Working
  • Surveillance & informatics

Antimicrobial-specific guidance

  • Home
  • /
  • Guidance & QI Tools
  • /
  • Antimicrobial-specific guidance

Antimicrobial-specific guidance

We have developed national guidance to support the safe and effective use of specific antibiotics that require individualised dosing has been developed based on available evidence and best practice. 

  • Aminoglycoside use in empirical prescribing guidelines

  • Chloramphenicol prescribing in adult patients - consensus guidance

  • Guidance on the intravenous use of colistimethate sodium (colistin) in adults

  • Guidance on the use of co-trimoxazole in secondary care in NHS Scotland

  • Gentamicin (NHS Greater Glasgow & Clyde)

  • Gentamicin (Hartford)

  • Updated MHRA fluoroquinolone advice

  • Vancomycin

 

clinician hands using syringe

Guidance & QI Tools

  • Antimicrobial-specific guidance
    • Aminoglycoside use in empirical prescribing guidelines
    • Chloramphenicol prescribing in adult patients - consensus guidance
    • Guidance on the intravenous use of colistimethate sodium (colistin) in adults
    • Gentamicin (5mg/kg)
    • Gentamicin - Hartford (7mg/kg)
    • Vancomycin
    • Statement on updated MHRA fluoroquinolone advice
  • Infection-specific guidance
  • Good practice recommendations
  • Dental stewardship
  • Outpatient parenteral antimicrobial therapy (OPAT)
  • Paediatric stewardship
  • Information for patients and non-clinical staff
  • Quality improvement tools
  • Guidance from other organisations
  • Right Decision Service App - Antimicrobial guidance
  • Accessibility
  • Privacy policy
  • Terms and conditions

© Scottish Antimicrobial Prescribing Group 

  • NHS Scotland Logo